Gene Biotherapeutics, Inc.
CRXM · OTC
12/31/2020 | 9/30/2020 | 6/30/2020 | 3/31/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $386 | $782 | $1,312 | $3 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $25 | $19 | $20 | $112 |
| Total Curr. Assets | $411 | $801 | $1,333 | $115 |
| Property Plant & Equip (Net) | $149 | $167 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $7 | $7 | $7 | $13 |
| Total NC Assets | $156 | $174 | $9 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $567 | $975 | $1,342 | $130 |
| Liabilities | – | – | – | – |
| Payables | $746 | $662 | $822 | $1,040 |
| Short-Term Debt | $1,084 | $1,142 | $941 | $972 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $0 | $0 | $0 |
| Total Curr. Liab. | $5,027 | $4,927 | $4,745 | $4,903 |
| LT Debt | $26 | $26 | $275 | $246 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $108 | $127 | $275 | $246 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $150 | $168 | $0 | $0 |
| Total Liabilities | $5,135 | $5,054 | $5,019 | $5,148 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4 | $3 | $2 | $1 |
| Retained Earnings | -$119,430 | -$118,987 | -$118,626 | -$119,062 |
| AOCI | $0 | $0 | $0 | $600 |
| Other Equity | $1 | $1 | $0 | $1 |
| Total Equity | -$3,875 | -$3,432 | -$3,071 | -$4,440 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$693 | -$646 | -$606 | -$579 |
| Total Liab. & Tot. Equity | $567 | $975 | $1,342 | $130 |
| Net Debt | $724 | $386 | -$97 | $1,215 |